Inmunohistochemical expression of thymidilate synthase, ERCC1, pKDR, and LDH5 as predcitive markers of efficacy in patients with advanced colon cancer treated with XELOX or FOLFOX with or without bevacizumab.

被引:0
|
作者
Garde, Javier
Evgenyeva, Elena
Raga Mireia, Gil
Bernet, Laia
Juarez, Asuncion
Laforga, Juan
Manuel Gassent, Juan
Demarchi, Martin
Camps, Carlos
Llombart, Antonio
机构
[1] Hosp Arnau Vilanova, Valencia, Spain
[2] Hosp Marinasalud, Denia, Spain
[3] Hosp Sagunto, Valencia, Spain
[4] Hosp Lluis Alcanyis, Xativa, Spain
[5] Hosp Gen Elda, Elda, Spain
[6] Hosp Marinasalud Denia, Denia, Spain
[7] Ctr Hosp Univ, Besancon, France
[8] Consorcio Hosp Gen Univ Valencia, Valencia, Spain
[9] Hosp Arnau de Vilanova Lleida, Lleida, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14671
引用
收藏
页数:1
相关论文
共 3 条
  • [1] Clinicopathologic significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapy
    Kim, Ki Han
    Kwon, Hyuk-Chan
    Oh, Sung Yong
    Kim, Sung Hyun
    Lee, Suee
    Kwon, Kyung A.
    Jang, Jin Seok
    Kim, Min Chan
    Kim, Su-Jin
    Kim, Hyo-Jin
    [J]. BIOMARKERS, 2011, 16 (01) : 74 - 82
  • [2] Clinicopathologic significance of ERCC1, Thymidylate Synthase and Glutathione S-Transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapy
    Oh, Sung Yong
    Kim, Ki Han
    Kim, Sung Hyun
    Lee, Suee
    Kwon, Kyung-A
    Jang, Jin Seok
    Kim, Min Chan
    Kim, Su-Jin
    Kim, Hyo-Jin
    Kwon, Hyuk-Chan
    [J]. CANCER RESEARCH, 2010, 70
  • [3] Wt Kras and gene expression levels of VEGFR2, EGFR, and ERCC-1 associated with progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC) treated with first-line 5-FU or capecitabine with oxaliplatin and bevacizumab (FOLFOX/BV or XELOX/BV)
    El-Khoueiry, A. B.
    Pohl, A.
    Danenberg, K.
    Cooc, J.
    Zhang, W.
    Yang, D.
    Singh, H.
    Shriki, J.
    Iqbal, S.
    Lenz, H. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)